drugset / Trial / NCT04282954
Clinical Trial to Evaluate the Safety and Efficacy of JP-1366 in Patients With Erosive Gastroesophageal Reflux Disease
RandomizedParallel-groupQuadruple-blindTreatment
Summary
Clinical trial to evaluate the safety and efficacy of JP-1366 in patients with erosive gastroesophageal reflux disease
Timeline
- Start
- 2019-11-15
- Primary completion
- 2020-10-20
- Completion
- 2020-12-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Esomeprazole | Small molecule | 40 mg | — |
| Subject | JP-1366 | Unknown | — | — |